Загрузка...
The IMPACT of triple versus dual single-inhaler therapy on exacerbations of COPD
In the IMPACT trial, triple inhalation therapy resulted in a lower rate of moderate or severe COPD exacerbations compared with either dual therapy with ICS/LABA or LAMA/LABA, but pneumonia rates were increased. http://ow.ly/pYJn30mgpFp
Сохранить в:
| Опубликовано в: : | Breathe (Sheff) |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
European Respiratory Society
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6269168/ https://ncbi.nlm.nih.gov/pubmed/30519302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/20734735.026418 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|